Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Saved in:
| Title: | Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy. |
|---|---|
| Authors: | Taskinen MR; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland., Matikainen N; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland.; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Björnson E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Söderlund S; Research Programs Unit, Clinical and Molecular Medicine, University of Helsinki, Helsinki, Finland.; Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland., Inkeri J; HUS Medical Imaging Center, Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Hakkarainen A; HUS Medical Imaging Center, Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Parviainen H; HUS Medical Imaging Center, Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Sihlbom C; Proteomic Core Facility at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Thorsell A; Proteomic Core Facility at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Andersson L; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Adiels M; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Packard CJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Borén J; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. jan.boren@wlab.gu.se.; Wallenberg Laboratory, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. jan.boren@wlab.gu.se. |
| Source: | Diabetologia [Diabetologia] 2023 Dec; Vol. 66 (12), pp. 2307-2319. Date of Electronic Publication: 2023 Sep 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
